As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on ...

while also promising new ones on pharmaceuticals and semiconductors. After 4 p.m. ET, stock indexes continued to drift lower ...

Moderna (MRNA) is another interesting choice today. MRNA stock has dropped 11.66% alongside the FDA news, the largest of the ...

India's benchmark indexes opened lower on Thursday after U.S. President Donald Trump slapped 26% reciprocal tariffs on ...

European healthcare stocks tumble as Trump prepares new tariffs, with pharmaceutical firms bracing for economic fallout and market uncertainty.

President Donald Trump on Wednesday announced a slew of tougher-than-anticipated tariffs, but there are some notable ...

Shares of Phathom Pharmaceuticals fell after the company said Chief Executive Officer Terrie Curran has resigned and will be succeeded by SaNOtize's Steven Basta. The stock declined 22% to $4.88 on ...

The delisting action was determined after Virpax Pharmaceuticals failed to regain compliance with Nasdaq Listing Rule 5550 (b) (1). The delisting process will conclude with the filing of a Form 25 ...

with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been a 0.1% fall in the Zacks Consensus EPS estimate. At present, Vertex Pharmaceuticals boasts ...

Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...